Peter Altman insider trades
Open-market stock purchases and sales by Peter Altman, President and CEO at BioCardia, Inc, from SEC Form 4 filings since Feb 1, 2018.
Track record: 7% of 91 scored buys are up 5% or more since purchase, averaging -40%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 16, 2026 | BCDA BioCardia, Inc | Bought | $285 |
| Oct 15, 2026 | BCDA BioCardia, Inc | Bought | $190 |
| Sep 29, 2026 | BCDA BioCardia, Inc | Bought | $1K |
| Sep 23, 2026 | BCDA BioCardia, Inc | Bought | $2K |
| Sep 3, 2026 | BCDA BioCardia, Inc | Bought | $872 |
| Aug 17, 2026 | BCDA BioCardia, Inc | Bought | $5K |
| Aug 13, 2026 | BCDA BioCardia, Inc | Bought | $1.7K |
| Jul 29, 2026 | BCDA BioCardia, Inc | Bought | $3.9K |
| Jul 17, 2026 | BCDA BioCardia, Inc | Bought | $415 |
| Jul 15, 2026 | BCDA BioCardia, Inc | Bought | $1.3K |
| Jul 14, 2026 | BCDA BioCardia, Inc | Bought | $2.5K |
| Jul 10, 2026 | BCDA BioCardia, Inc | Bought | $940 |
| Jul 9, 2026 | BCDA BioCardia, Inc | Bought | $900 |
| Jul 8, 2026 | BCDA BioCardia, Inc | Bought | $5.2K |
| Jul 8, 2026 | BCDA BioCardia, Inc | Bought | $5.3K |
| Jul 6, 2026 | BCDA BioCardia, Inc | Bought (not open market) | — |
| Jul 2, 2026 | BCDA BioCardia, Inc | Sold (not open market) | $67.7K |
| Jun 29, 2026 | BCDA BioCardia, Inc | Bought (not open market) | $133K |
| Jun 18, 2026 | BCDA BioCardia, Inc | Bought | $768 |
| Jun 17, 2026 | BCDA BioCardia, Inc | Bought | $1.3K |
| Jun 9, 2026 | BCDA BioCardia, Inc | Bought | $4.3K |
| May 20, 2026 | BCDA BioCardia, Inc | Bought | $1.4K |
| May 19, 2026 | BCDA BioCardia, Inc | Bought | $190 |
| May 18, 2026 | BCDA BioCardia, Inc | Bought | $5.2K |
| May 15, 2026 | BCDA BioCardia, Inc | Bought | $5.2K |
Companies traded
- BCDA BioCardia, Inc: 103 buys, last Oct 16, 2026
- BCDA;BCDAW BioCardia, Inc: 43 buys, 1 sale, last Jul 1, 2024